OTC - ACTIVE INGREDIENT SECTION
KETOCONAZOLE 1%
KETOCONAZOLE 1%
Anti-dandruff shampoos
Controls flaking, scaling and itching associated with dandruff.
For external use only.
on scalp that is broken or inflamed.
if you are allergic to ingredients in this product.
When using this products. Avoid contact with eyes.
If contact occurs, rinse thoroughly with water.
Stop use and ask a doctor if
rash appears.
condition worsens or does not improve in 2-4 weeks.
If pregnant or breast-feeding, ask a doctor before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center righta way.
For adults and children 12 years and older:
1. Wet hair thoroughly.
2. Apply shampoos, generously lather, rinse thoroughly. Repeat.
3. Use every 3-4 days for up to 8 weeks or as
directed by a doctor. Then use only as needed to control dandruff.
Children under 12 years: Ask a doctor.
WATER
SODIUM LAUROYL SARCOSINATE
COCAMIDOPROPYL BETAINE
PARFUM
GLYCERYL CAPRYLATE
GLYCERYL LAURATE
PHENOXYETHANOL
LAURYL LACTATE
CITRIC ACID
POLYQUATERNIUM-10
DISODIUM EDTA
HYDROLYZED RHODOPHYCEAE EXTRACT
BUTYLENE GLYCOL
1,2-HEXANEDIOL
PENTYLENE GLYCOL
PROPANEDIOL
CAPRYLHYDROXAMIC ACID
ETHYLHEXYLGLYCERIN
BIOTIN
POTASSIUM HYDROXIDE
label
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 87681-009 | 87681-009-01, 87681-009-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5792eff5-632f-3664-e063-6394a90a8ae3 | 5792eff5-632e-3664-e063-6394a90a8ae3 | 2026-07-27 | Warnings | 5792eff5-632f-3664-e063-6394a90a8ae3 5792eff5-632e-3664-e063-6394a90a8ae3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.